DYRK2 and breast cancer: Based on single-cell RNA sequencing datasets, a clear overlap between DYRK2 and HSF1 was detected in the clustered cell populations of renal cell carcinoma, colon adenocarcinoma, breast cancer, and astrocytoma [44].